AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

NCT02082262 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
140
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Allergan